Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.41.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.41.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15620.7Singapore
XBB.1.41.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.4.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.4.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JF.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JF.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JF.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JG.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JG.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBBNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBBNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBBNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.6.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.6.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.6.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.4.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.4.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used